Emerging Role and Therapeutic Potential of lncRNAs in Colorectal Cancer
Open Access
Abstract
Maintenance of the intestinal epithelium is dependent on the control of stem cell (SC) proliferation and differentiation. The fine regulation of these cellular processes requires a complex dynamic interplay between several signaling pathways, including Wnt, Notch, Hippo, EGF, Ephrin, and BMP/TGF-β. During the initiation and progression of colorectal cancer (CRC), key events, such as oncogenic mutations, influence these signaling pathways, and tilt the homeostatic balance towards proliferation and dedifferentiation. Therapeutic strategies to specifically target these deregulated signaling pathways are of particular interest. However, systemic blocking or activation of these pathways poses major risks for normal stem cell function and tissue homeostasis. Interestingly, long non-coding RNAs (lncRNAs) have recently emerged as potent regulators of key cellular processes often deregulated in cancer. Because of their exceptional tissue and tumor specificity, these regulatory RNAs represent attractive targets for cancer therapy. Here, we discuss how lncRNAs participate in the maintenance of intestinal homeostasis and how they can contribute to the deregulation of each signaling pathway in CRC. Finally, we describe currently available molecular tools to develop lncRNA-targeted cancer therapies.Keywords
Funding Information
- KWF Kankerbestrijding (12228)
This publication has 188 references indexed in Scilit:
- Control of somatic tissue differentiation by the long non-coding RNA TINCRNature, 2012
- Landscape of transcription in human cellsNature, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signallingNature Cell Biology, 2012
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor SuppressorCell, 2012
- Paneth cells constitute the niche for Lgr5 stem cells in intestinal cryptsNature, 2010
- Dissociation of EphB2 Signaling Pathways Mediating Progenitor Cell Proliferation and Tumor SuppressionCell, 2009
- Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2EMBO Reports, 2008
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007
- APC mutations occur early during colorectal tumorigenesisNature, 1992